{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:22:47Z","timestamp":1786990967451,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Scientific Research Foundation of Wenzhou, Zhejiang Province, China","award":["Y20100180"],"award-info":[{"award-number":["Y20100180"]}]},{"name":"Scientific Research Foundation of Wenzhou, Zhejiang Province, China","award":["Y20140073"],"award-info":[{"award-number":["Y20140073"]}]},{"name":"Medicine Health Project of Zhejiang Province, China","award":["2014KYB155"],"award-info":[{"award-number":["2014KYB155"]}]},{"name":"Five-year science and technology major projects","award":["2012ZX10002004-010"],"award-info":[{"award-number":["2012ZX10002004-010"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.imlet.2014.10.021","type":"journal-article","created":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T19:32:48Z","timestamp":1414524768000},"page":"222-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"PB","title":["Mesenchymal stem cells ameliorate experimental autoimmune hepatitis by activation of the programmed death 1 pathway"],"prefix":"10.1016","volume":"162","author":[{"given":"Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-Lin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Guo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Man","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2014.10.021_bib0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-1-2","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease","volume":"1","author":"Zachou","year":"2004","journal-title":"J Autoimmun Dis"},{"key":"10.1016\/j.imlet.2014.10.021_bib0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11894-011-0236-2","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"14","author":"Vierling","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.imlet.2014.10.021_bib0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.autrev.2005.01.005","article-title":"T cell immunity in autoimmune hepatitis","volume":"4","author":"Ichiki","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.imlet.2014.10.021_bib0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imlet.2014.10.021_bib0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/apt.12042","article-title":"Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs","volume":"36","author":"Selvarajah","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.imlet.2014.10.021_bib0030","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrrheum.2009.104","article-title":"Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases","volume":"5","author":"Djouad","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.imlet.2014.10.021_bib0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","article-title":"Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo","volume":"30","author":"Bartholomew","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.imlet.2014.10.021_bib0040","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood-2003-04-1193","article-title":"Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals","volume":"102","author":"Djouad","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2014.10.021_bib0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaut.2007.10.001","article-title":"Interleukin-27 suppresses experimental autoimmune encephalomyelitis during bone marrow stromal cell treatment","volume":"30","author":"Wang","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.imlet.2014.10.021_bib0050","doi-asserted-by":"crossref","first-page":"e14247","DOI":"10.1371\/journal.pone.0014247","article-title":"IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis","volume":"5","author":"Bouffi","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imlet.2014.10.021_bib0055","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4049\/jimmunol.0902007","article-title":"Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype","volume":"185","author":"Ghannam","year":"2010","journal-title":"J Immunol (Baltimore, MD: 1950)"},{"key":"10.1016\/j.imlet.2014.10.021_bib0060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3904\/kjim.2013.28.4.387","article-title":"Clinical applications of mesenchymal stem cells","volume":"28","author":"Kim","year":"2013","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.imlet.2014.10.021_bib0065","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.imlet.2014.10.021_bib0070","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nri727","article-title":"The B7-CD28 superfamily","volume":"2","author":"Sharpe","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.imlet.2014.10.021_bib0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.immunol.20.091101.091806","article-title":"The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses","volume":"20","author":"Carreno","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.imlet.2014.10.021_bib0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2009.00767.x","article-title":"PD-1 signaling in primary T cells","volume":"229","author":"Riley","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.imlet.2014.10.021_bib0085","doi-asserted-by":"crossref","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","author":"Freeman","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2014.10.021_bib0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1440-1827.2007.02129.x","article-title":"Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease","volume":"57","author":"Oikawa","year":"2007","journal-title":"Pathol Int"},{"key":"10.1016\/j.imlet.2014.10.021_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2010.05919.x","article-title":"The role of the PD-1 pathway in autoimmunity and peripheral tolerance","volume":"1217","author":"Fife","year":"2011","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.imlet.2014.10.021_bib0100","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/cr.2008.80","article-title":"A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1","volume":"18","author":"Sheng","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.imlet.2014.10.021_bib0105","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.imlet.2014.10.021_bib0110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.imlet.2014.10.021_bib0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2217\/1750743X.1.2.199","article-title":"Th17 cells in autoimmune disease: changing the verdict","volume":"1","author":"Haak","year":"2009","journal-title":"Immunotherapy"},{"key":"10.1016\/j.imlet.2014.10.021_bib0120","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1053\/j.gastro.2009.08.004","article-title":"Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production","volume":"137","author":"Lafdil","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.imlet.2014.10.021_bib0125","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.4049\/jimmunol.181.11.7473","article-title":"Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells","volume":"181","author":"Nagata","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.10.021_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2014.10.021_bib0135","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation","volume":"198","author":"Murphy","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2014.10.021_bib0140","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2014.10.021_bib0145","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-013-2469-y","article-title":"Involvement of IL-23 in enteropathic arthritis patients with inflammatory bowel disease: preliminary results","author":"Gheita","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.imlet.2014.10.021_bib0150","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.4049\/jimmunol.1002031","article-title":"The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance","volume":"187","author":"D\u2019Addio","year":"2011","journal-title":"J Immunol (Baltimore, MD: 1950)"},{"key":"10.1016\/j.imlet.2014.10.021_bib0155","doi-asserted-by":"crossref","first-page":"e45272","DOI":"10.1371\/journal.pone.0045272","article-title":"Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway","volume":"7","author":"Luz-Crawford","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.imlet.2014.10.021_bib0160","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/hep.510270611","article-title":"Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression","volume":"27","author":"Lohse","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.imlet.2014.10.021_bib0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.1840110106","article-title":"Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity","volume":"11","author":"Lohse","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.imlet.2014.10.021_bib0170","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.imlet.2014.10.021_bib0175","doi-asserted-by":"crossref","first-page":"G525","DOI":"10.1152\/ajpgi.00286.2002","article-title":"Impairment of TGF-beta signaling in T cells increases susceptibility to experimental autoimmune hepatitis in mice","volume":"284","author":"Schramm","year":"2003","journal-title":"Am J Physiol: Gastrointest Liver Physiol"},{"key":"10.1016\/j.imlet.2014.10.021_bib0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.it.2011.11.004","article-title":"How mesenchymal stem cells interact with tissue immune responses","volume":"33","author":"Shi","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.imlet.2014.10.021_bib0185","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1634\/stemcells.2006-0228","article-title":"Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease","volume":"24","author":"Yanez","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.imlet.2014.10.021_bib0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.trim.2011.06.002","article-title":"Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model","volume":"25","author":"Eggenhofer","year":"2011","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.imlet.2014.10.021_bib0195","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2003-09-3070","article-title":"Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential","volume":"103","author":"Peister","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2014.10.021_bib0200","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3109\/14653249.2012.729817","article-title":"Is CD34 truly a negative marker for mesenchymal stromal cells","volume":"14","author":"Lin","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.imlet.2014.10.021_bib0205","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1182\/blood.V78.11.2848.2848","article-title":"CD34 expression by stromal precursors in normal human adult bone marrow","volume":"78","author":"Simmons","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2014.10.021_bib0210","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/14653240701358445","article-title":"BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype","volume":"9","author":"Kaiser","year":"2007","journal-title":"Cytotherapy"},{"key":"10.1016\/j.imlet.2014.10.021_bib0215","article-title":"Expression of programmed death 1 and its ligands in the liver of autoimmune hepatitis C57BL\/6 mice","author":"Cao","year":"2009","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.imlet.2014.10.021_bib0220","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/hep.23173","article-title":"Chronically inflamed livers up-regulate expression of inhibitory B7 family members","volume":"50","author":"Kassel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.imlet.2014.10.021_bib0225","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/scrt216","article-title":"Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells","volume":"4","author":"Luz-Crawford","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.imlet.2014.10.021_bib0230","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/eji.200425405","article-title":"Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway","volume":"35","author":"Augello","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.imlet.2014.10.021_bib0235","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.immuni.2012.03.024","article-title":"Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1","volume":"36","author":"Hirahara","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2014.10.021_bib0240","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.imlet.2014.10.021_bib0245","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2014.10.021_bib0250","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/eji.201242598","article-title":"IL-23: one cytokine in control of autoimmunity","volume":"42","author":"Croxford","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.imlet.2014.10.021_bib0255","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1002\/eji.201141291","article-title":"Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production","volume":"41","author":"Xu","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.imlet.2014.10.021_bib0260","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.12290","article-title":"Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis","author":"Olewicz-Gawlik","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.imlet.2014.10.021_bib0265","first-page":"798","article-title":"Therapeutic effect of allogenic bone marrow mesenchymal stem cell transplantation on EAE mouse","volume":"29","author":"Liu","year":"2013","journal-title":"Xi bao yu fen zi mian yi xue za zhi"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247814002405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247814002405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T01:58:24Z","timestamp":1598407104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247814002405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0165247814002405"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2014.10.021","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stem cells ameliorate experimental autoimmune hepatitis by activation of the programmed death 1 pathway","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2014.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}